Cogstate Ltd (AU:CGS) has released an update.
Cogstate Ltd reported a significant year-over-year increase in profits, with a 134.8% jump in profit before income tax to $7.1 million for the financial year ending 30 June 2024. Total revenue rose by 7.4% to $43.4 million, driven by a robust 9.4% growth in Clinical Trials revenue, despite a 9.5% decrease in Healthcare revenue. The company did not declare any dividends for the year, mirroring the previous year’s decision.
For further insights into AU:CGS stock, check out TipRanks’ Stock Analysis page.
